COVID-19

Biden signs bill to increase US national debt ceiling

President Joe Biden signed into law, expanding the US government debt ceiling and preventing a potential default on government debt. This significant step was the result of months of political negotiations and includes a number of key measures, reflecting economic and political dynamics within the country. In this article, we will take a closer look at the key points and implications of this decision., which, As expected, will lead to some changes in the US economic landscape.

News digest on 3 november 2022

The Bank of England will decide today to raise its base interest rate by 0.75%*. The yuan against the dollar* updated the minimum since 22 January 2008 of the year. Courses: ? Bitcoin – $20 710 (↑1,12%) ? S&P 500 – 3 876 (↑0,53%) ?? USD/RUB – 60,60 (↓1,86%) ?? USD/UAH – 36,88 (↑0,00%) ? Gold – $1 667 (↑0,99%) ⚫️ Oil Brent – $94,59 (↑0,49%) ⚡️ The Fed has raised rates on 75 b. P. The US regulator raised the key rate on 75 basis points, up to 3.75–4%. This is the fourth consecutive increase in 0,75 p.p.. The current rate level is the highest since December 2007 of the year. This is the expected solution., he was expected 87,5% investors, according to CME FedWatch Tool. At the same time, many are waiting for signals from Fed Chairman Jerome Powell about a slowdown in rate hikes.. 45% investors are counting, that at the next meeting the indicator will be raised by 0,5 P. P. (49,2% sure, that the next step will also be 0,75 P. P.). The Fed will hold its last meeting of the year 14 December.

Rosseti joins FGC UES. What investors need to know

15 July 2022, after the close of the main trading session, the Moscow Exchange Rosseti and FGC UES announced the convening of extraordinary meetings of shareholders (VOSA), within the framework of which they raised the issue of reorganizing the two societies in the form of joining each other.

Overview of Atea Pharmaceuticals: antiviral biotech

Atea PharmaceuticalsAVIR7.38 $ Atea Pharmaceuticals (Nasdaq: AVIR) — American pharmaceutical company, which appeared in 2012 in Boston, Massachusetts, and develops antiviral agents in the clinical stages.

Scroll to Top